Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 59% ± 16% | |
brain | 20 studies | 34% ± 12% | |
lung | 19 studies | 57% ± 17% | |
intestine | 12 studies | 49% ± 22% | |
eye | 11 studies | 44% ± 18% | |
kidney | 9 studies | 55% ± 14% | |
liver | 7 studies | 50% ± 21% | |
lymph node | 6 studies | 60% ± 17% | |
bone marrow | 5 studies | 51% ± 21% | |
uterus | 5 studies | 66% ± 15% | |
prostate | 5 studies | 48% ± 18% | |
pancreas | 4 studies | 51% ± 13% | |
placenta | 4 studies | 71% ± 22% | |
adipose | 4 studies | 27% ± 16% | |
breast | 4 studies | 62% ± 7% | |
heart | 3 studies | 36% ± 10% | |
adrenal gland | 3 studies | 54% ± 11% | |
esophagus | 3 studies | 58% ± 27% | |
skin | 3 studies | 54% ± 8% | |
thymus | 3 studies | 75% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 27785.05 | 459 / 459 | 100% | 445.32 | 1118 / 1118 |
esophagus | 100% | 25752.81 | 1445 / 1445 | 100% | 267.67 | 183 / 183 |
lung | 100% | 26162.79 | 578 / 578 | 100% | 326.48 | 1155 / 1155 |
ovary | 100% | 28417.12 | 180 / 180 | 100% | 249.22 | 430 / 430 |
prostate | 100% | 21671.80 | 245 / 245 | 100% | 364.56 | 502 / 502 |
stomach | 100% | 19588.61 | 359 / 359 | 100% | 291.05 | 286 / 286 |
uterus | 100% | 27833.86 | 170 / 170 | 100% | 389.50 | 459 / 459 |
kidney | 100% | 19834.44 | 89 / 89 | 100% | 278.05 | 900 / 901 |
brain | 100% | 18103.02 | 2639 / 2642 | 100% | 371.30 | 705 / 705 |
thymus | 100% | 26630.88 | 653 / 653 | 100% | 362.45 | 604 / 605 |
intestine | 100% | 25694.67 | 966 / 966 | 100% | 332.75 | 526 / 527 |
bladder | 100% | 24974.62 | 21 / 21 | 100% | 330.07 | 503 / 504 |
skin | 100% | 31761.98 | 1809 / 1809 | 100% | 346.53 | 471 / 472 |
liver | 100% | 14119.98 | 226 / 226 | 100% | 196.01 | 405 / 406 |
pancreas | 99% | 13583.58 | 326 / 328 | 100% | 287.57 | 178 / 178 |
adrenal gland | 100% | 27418.12 | 258 / 258 | 99% | 272.16 | 227 / 230 |
adipose | 100% | 28182.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 24431.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 256.44 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 394.32 | 29 / 29 |
muscle | 100% | 19801.16 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 29028.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 376.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 139.94 | 1 / 1 |
peripheral blood | 99% | 27555.55 | 920 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 15881.90 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006396 | Biological process | RNA processing |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007165 | Biological process | signal transduction |
GO_0010988 | Biological process | regulation of low-density lipoprotein particle clearance |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0048260 | Biological process | positive regulation of receptor-mediated endocytosis |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_1902165 | Biological process | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_1905599 | Biological process | positive regulation of low-density lipoprotein receptor activity |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0002102 | Cellular component | podosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0000785 | Cellular component | chromatin |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HNRNPK |
Protein name | Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP) Heterogeneous nuclear ribonucleoprotein K |
Synonyms | HNRPK |
Description | FUNCTION: One of the major pre-mRNA-binding proteins. Binds tenaciously to poly(C) sequences. Likely to play a role in the nuclear metabolism of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich sequences. Can also bind poly(C) single-stranded DNA. Plays an important role in p53/TP53 response to DNA damage, acting at the level of both transcription activation and repression. When sumoylated, acts as a transcriptional coactivator of p53/TP53, playing a role in p21/CDKN1A and 14-3-3 sigma/SFN induction (By similarity). As far as transcription repression is concerned, acts by interacting with long intergenic RNA p21 (lincRNA-p21), a non-coding RNA induced by p53/TP53. This interaction is necessary for the induction of apoptosis, but not cell cycle arrest. As part of a ribonucleoprotein complex composed at least of ZNF827, HNRNPL and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation . . |
Accessions | ENST00000704013.1 ENST00000704004.1 [P61978-3] ENST00000704059.1 [P61978-2] ENST00000457156.6 ENST00000704054.1 ENST00000704051.1 [P61978-1] ENST00000704056.1 S4R359 A0A994J6T5 ENST00000704010.1 S4R457 ENST00000704006.1 [P61978-1] ENST00000704016.1 ENST00000704009.1 A0A994J4U9 B4DUQ1 ENST00000704005.1 [P61978-2] ENST00000481820.6 ENST00000376281.8 [P61978-2] ENST00000472778.6 ENST00000376263.8 [P61978-2] A0A994J4S7 ENST00000457156.6 [P61978-3] ENST00000704057.1 [P61978-2] ENST00000704008.1 ENST00000704052.1 [P61978-1] ENST00000704053.1 [P61978-1] ENST00000704060.1 ENST00000704015.1 P61978 A0A994J795 ENST00000704055.1 ENST00000704007.1 ENST00000360384.9 [P61978-1] A0A994J6U9 Q5T6W2 ENST00000704012.1 ENST00000704011.1 [P61978-2] A0A994J4E9 A0A994J782 ENST00000704014.1 ENST00000704058.1 [P61978-1] ENST00000351839.7 [P61978-1] |